Keyphrases
Adjuvant Agent
25%
Antigenic Site
50%
Biofunctional Materials
25%
Carbon Tetrachloride
25%
Cell Factory
25%
Escherichia Coli
50%
Foot-and-mouth Disease Virus
50%
Fully Scalable
25%
High Dose
25%
Highly Stable
50%
Human Disease
25%
Immunogenic
50%
Insertion Site
50%
Intrinsic Limits
25%
Lethal Infection
25%
Mechanically Stable
25%
Medical Use
25%
MIP-1b
25%
Monoclonal Antibody
50%
Multiple Insertions
50%
Nanostructures
50%
Physicochemical Conditions
25%
Polyclonal Sera
50%
Production Cost
25%
Protein Engineering
50%
Pseudomonas Aeruginosa (P. aeruginosa)
25%
Recombinant
100%
Recombinant Cells
25%
Recombinant Cytokines
50%
Recombinant Peptide
50%
Recombinant Protein
50%
Scalable Process
25%
Short Half-life
25%
Synthetic Peptides
100%
Therapeutic Agents
25%
Undesirable Side Effects
25%
Viral Infection
50%
Viral Peptides
50%
Zebrafish
25%
β-Galactosidase (β-Gal)
50%
Immunology and Microbiology
Escherichia coli
100%
Foot and Mouth Disease Virus
100%
Immunology
100%
Monoclonal Antibody
100%
Protein Engineering
100%
Viral Disease
100%
Pharmacology, Toxicology and Pharmaceutical Science
Adjuvant
16%
Cytokine
50%
Disease
16%
Infection
16%
Pseudomonas aeruginosa
16%
Recombinant Cytokine
50%
Side Effect
16%
Tumor Necrosis Factor
16%
Zebra Fish
16%